PSNL — Personalis, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1527753 ·
Last close
$16.46
Market Cap
$1.76B
52W High
$18.89
52W Low
$4.95
ADV30
3,213,310
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 22,357,000 | 4,743,000 | -33,591,000 | -31,683,000 | 312,135,000 | 93,968,000 | 76,974,000 |
| Mar 2026 | 15,472,000 | 281,000 | -32,161,000 | -30,032,000 | 325,395,000 | 73,594,000 | 70,630,000 |
| Dec 2025 | 17,345,000 | 1,900,000 | -25,266,000 | -23,812,000 | 334,164,000 | 124,245,000 | 72,979,000 |
| Sep 2025 | 14,495,000 | 1,914,000 | -23,291,000 | -21,652,000 | 242,839,000 | 49,973,000 | 71,424,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-92,298,000
Investing CF
$-3,504,000
Financing CF
$136,396,000
CapEx
$-8,677,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.09
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-692,975,000
Inventory
$7,747,000
Receivables
$15,102,000
ST Investments
$118,690,000
EBIT TTM
$-106,933,000
Pretax Income TTM
$-107,146,000
Interest Exp TTM
$213,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$69,669,000
EBITDA
$-104,596,000
Free Cash Flow
$-56,028,248
Enterprise Value
$1,556,563,968
Total Cash
$212,658,000
Total Debt
$37,996,000
Shares Out
106,799,872
Trailing EPS
$-1.09
Book Value
$2.21
ROE
-50.3%
ROA
-25.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 69,648,000 | -88,057,000 | -81,270,000 | 334,164,000 | 72,979,000 | 261,185,000 | -74,946,000 |
| Dec 2024 | 84,614,000 | -68,267,000 | -81,284,000 | 270,268,000 | 67,311,000 | 202,957,000 | -45,150,000 |
| Dec 2023 | 73,481,000 | -96,294,000 | -108,296,000 | 225,099,000 | 95,658,000 | 129,441,000 | -56,258,000 |
| Dec 2022 | 65,047,000 | -115,531,000 | -113,315,000 | 292,700,000 | 74,561,000 | 218,139,000 | -70,233,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.94
Max Pain — expiry 2026-10-16
max pain strike: $12.50 · spot: $16.37 · call oi: 11,654 · put oi: 798
Expected Move to 2026-10-16:
±$1.38
(8.40%) —
implied range
$15.00 –
$17.75
· ATM straddle on $17.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SNDA | SONIDA SENIOR LIVING, INC. | $1.81B | $37.71 | — |
| SGRY | Surgery Partners, Inc. | $1.89B | $14.40 | — |
| FTRE | Fortrea Holdings Inc. | $1.89B | $19.89 | — |
| PGNY | Progyny, Inc. | $1.95B | $25.44 | — |
| ARDT | Ardent Health, Inc. | $1.49B | $10.54 | — |
News headlines (Yahoo Finance, 1h cache)
Tempus AI (TEM) Jumped on Moderna’s Melanoma Win. Did its $1.5B Personalis Acquisition Just Get Validated?
2026-08-27 22:01 · Yahoo
Personalis Stock Is Up 250% in the Past Year. It Needs to Turn a Profit Next.
2026-08-26 15:50 · Yahoo
Sector Update: Healthcare Stocks Softer Late Afternoon
2026-08-24 19:47 · Yahoo
Tempus AI (TEM) Is Up 39.5% After mRNA Melanoma Trial Win And Personalis Deal - What's Changed
2026-08-22 08:08 · Yahoo
TEM Stock On Track For Best Week In 4 Months Following Personalis Deal Spotlight
2026-08-20 17:22 · Yahoo
Moderna’s Cancer Breakthrough Just Made Tempus AI’s $1.5 Billion Bet Look Brilliant
2026-08-19 18:44 · Yahoo
Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates
2026-08-04 21:15 · Yahoo
Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion
2026-09-22 00:02 · Yahoo
Piper Sandler Lifts Tempus AI to Overweight at $76
2026-09-01 13:45 · Yahoo
Tempus AI shares rise 2.7% following analyst actions
2026-09-01 13:36 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.